UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Journal of clinical pharmacology, 2010-07, Vol.50 (7), p.743-753

2010

Volltextzugriff (PDF)

Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans

Drug metabolism and disposition, 2012-12, Vol.40 (12), p.2250

2012

Volltextzugriff (PDF)

Newborn screening and diagnosis of mucopolysaccharidoses

Molecular genetics and metabolism, 2013-09, Vol.110 (1-2), p.42-53

2013

Volltextzugriff (PDF)

A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors

Investigational new drugs, 2020-02, Vol.38 (1), p.99-110

2020

Volltextzugriff (PDF)

Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry

Analytical biochemistry, 2007-09, Vol.368 (1), p.79-86

2007

Volltextzugriff (PDF)

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Novel Factor Xa Inhibitor DY-807f in Healthy Volunteers

Thrombosis research, 2015-04, Vol.135 (4), p.594-601

2015

Volltextzugriff (PDF)

Identification of Influx Transporter for the Quinolone Antibacterial Agent Levofloxacin

Molecular pharmaceutics, 2007-01, Vol.4 (1), p.85-94

2007

Volltextzugriff (PDF)

Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry

Molecular genetics and metabolism, 2010-02, Vol.99 (2), p.124-131

2010

Volltextzugriff (PDF)

Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I

Journal of inherited metabolic disease, 2010-04, Vol.33 (2), p.141-150

2010

Volltextzugriff (PDF)

Computational pathology–based HER2 quantification to identify novel biomarkers in gastric cancer (GC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.449-449

2023

Volltextzugriff (PDF)

Analytical Method for Keratan Sulfates by High-Performance Liquid Chromatography/Turbo-Ionspray Tandem Mass Spectrometry

Analytical biochemistry, 2001-03, Vol.290 (1), p.68-73

2001

Volltextzugriff (PDF)

Validation study of assay method for DE-310, a novel polymer-bound camptothecin derivative, and the free drug in mouse plasma by liquid chromatography with fluorimetric detection

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-03, Vol.801 (2), p.157-164

2004

Volltextzugriff (PDF)

Phase I and Pharmacological Study of a New Camptothecin Derivative, Exatecan Mesylate (DX-8951f), Infused Over 30 Minutes Every Three Weeks

Clinical cancer research, 2001-10, Vol.7 (10), p.3056-3064

2001

Volltextzugriff (PDF)

Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in human plasma by HPLC and LC/MS/MS

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-04, Vol.818 (2), p.249-256

2005

Volltextzugriff (PDF)

High-Performance Liquid Chromatographic Analysis of Lactone and Hydroxy Acid of New Antitumor Drug, DX-8951 (Exatecan), in Mouse Plasma

Biological and Pharmaceutical Bulletin, 2001, Vol.24(2), pp.176-180

2001

Volltextzugriff (PDF)

Enhancement of Drug Delivery: Enzyme-replacement Therapy for Murine Morquio A Syndrome

Molecular therapy, 2010-06, Vol.18 (6), p.1094-1102

2010

Volltextzugriff (PDF)

Abstract 760: A randomized, crossover, phase 1 study to evaluate the effect of a strong CYP3A4 inhibitor on tivantinib (ARQ 197) pharmacokinetics in healthy subjects

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.760-760

2012

Volltextzugriff (PDF)

Enzyme replacement therapy in a murine model of Morquio A syndrome

Human molecular genetics, 2008-03, Vol.17 (6), p.815-824

2008

Volltextzugriff (PDF)

Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: Early treatment rescues bone lesions?

Molecular genetics and metabolism, 2015-02, Vol.114 (2), p.195-202

2015

Volltextzugriff (PDF)

Abstract 755: A randomized, open-label, phase 1 study to evaluate the effect of food on tivantinib (ARQ 197) pharmacokinetics

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.755-755

2012

Volltextzugriff (PDF)

Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography–tandem mass spectrometry

Journal of inherited metabolic disease, 2010-12, Vol.33 (Suppl 3), p.35-42

2010

Volltextzugriff (PDF)

Sacral dimple: incidental findings from newborn evaluation (Case Presentation)

Acta Paediatrica, 2009-05, Vol.98 (5), p.768-769

2009

Volltextzugriff (PDF)

Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice

Molecular genetics and metabolism, 2008-06, Vol.94 (2), p.178-189

2008

Volltextzugriff (PDF)

Sacral dimple: incidental findings from newborn evaluation (Discussion and Diagnosis)

Acta Paediatrica, 2009-05, Vol.98 (5), p.910-912

2009

Volltextzugriff (PDF)

Analytical method of chondroitin/dermatan sulfates using high performance liquid chromatography/turbo ionspray ionization mass spectrometry: application to analyses of the tumor tissue sections on glass slides

Biomedical chromatography, 2001-08, Vol.15 (5), p.356-362

2001

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(63)

Publikationsform

Artikel
(71)

Sprache

Englisch
(70)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(56)
Humans
(32)
Animals
(28)
Clostridium Botulinum
(23)
Biological And Medical Sciences
(21)
Biochemistry & Molecular Biology
(20)
Mice
(17)
Botulinum Toxins - Chemistry
(15)
Molecular Sequence Data
(15)
Amino Acid Sequence
(14)
Microbiology
(13)
Botulinum Toxins - Metabolism
(12)
Fundamental And Applied Biological Sciences. Psychology
(12)
Medical Sciences
(12)
Pharmacology & Pharmacy
(12)
Chemistry
(11)
Male
(11)
Physical Sciences
(11)
Biochemistry
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans

Newborn screening and diagnosis of mucopolysaccharidoses

A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors

Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Novel Factor Xa Inhibitor DY-807f in Healthy Volunteers

Identification of Influx Transporter for the Quinolone Antibacterial Agent Levofloxacin

Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry

Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I

Computational pathology–based HER2 quantification to identify novel biomarkers in gastric cancer (GC)

Analytical Method for Keratan Sulfates by High-Performance Liquid Chromatography/Turbo-Ionspray Tandem Mass Spectrometry

Validation study of assay method for DE-310, a novel polymer-bound camptothecin derivative, and the free drug in mouse plasma by liquid chromatography with fluorimetric detection

Phase I and Pharmacological Study of a New Camptothecin Derivative, Exatecan Mesylate (DX-8951f), Infused Over 30 Minutes Every Three Weeks

Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in human plasma by HPLC and LC/MS/MS

High-Performance Liquid Chromatographic Analysis of Lactone and Hydroxy Acid of New Antitumor Drug, DX-8951 (Exatecan), in Mouse Plasma

Enhancement of Drug Delivery: Enzyme-replacement Therapy for Murine Morquio A Syndrome

Abstract 760: A randomized, crossover, phase 1 study to evaluate the effect of a strong CYP3A4 inhibitor on tivantinib (ARQ 197) pharmacokinetics in healthy subjects

Enzyme replacement therapy in a murine model of Morquio A syndrome

Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: Early treatment rescues bone lesions?

Abstract 755: A randomized, open-label, phase 1 study to evaluate the effect of food on tivantinib (ARQ 197) pharmacokinetics

Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography–tandem mass spectrometry

Sacral dimple: incidental findings from newborn evaluation (Case Presentation)

Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice

Sacral dimple: incidental findings from newborn evaluation (Discussion and Diagnosis)

Analytical method of chondroitin/dermatan sulfates using high performance liquid chromatography/turbo ionspray ionization mass spectrometry: application to analyses of the tumor tissue sections on glass slides

Aktive Filter

Suchergebnisse filtern